ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $92,498 | -62.4% | 4,965 | -47.6% | 0.00% | -100.0% |
Q2 2023 | $246,005 | -0.8% | 9,469 | +9.6% | 0.00% | 0.0% |
Q1 2023 | $248,084 | +81239.0% | 8,638 | -16.1% | 0.00% | 0.0% |
Q4 2022 | $305 | +26.6% | 10,299 | +1.7% | 0.00% | 0.0% |
Q3 2022 | $241 | -99.9% | 10,131 | +6.3% | 0.00% | 0.0% |
Q2 2022 | $212,000 | -10.2% | 9,535 | +1.8% | 0.00% | 0.0% |
Q1 2022 | $236,000 | -10.9% | 9,366 | +26.6% | 0.00% | 0.0% |
Q4 2021 | $265,000 | -22.7% | 7,396 | -8.0% | 0.00% | 0.0% |
Q3 2021 | $343,000 | -7.0% | 8,036 | -5.8% | 0.00% | 0.0% |
Q2 2021 | $369,000 | +3.7% | 8,528 | -2.3% | 0.00% | 0.0% |
Q1 2021 | $356,000 | -5.6% | 8,731 | +4.6% | 0.00% | -50.0% |
Q4 2020 | $377,000 | +25.7% | 8,347 | -1.5% | 0.00% | +100.0% |
Q3 2020 | $300,000 | -6.0% | 8,475 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $319,000 | +23.6% | 8,475 | -5.3% | 0.00% | +100.0% |
Q1 2020 | $258,000 | -46.1% | 8,946 | -3.2% | 0.00% | -50.0% |
Q4 2019 | $479,000 | -16.3% | 9,241 | -11.4% | 0.00% | -33.3% |
Q3 2019 | $572,000 | +136.4% | 10,429 | +74.9% | 0.00% | +200.0% |
Q2 2019 | $242,000 | +34.4% | 5,962 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $180,000 | -18.6% | 5,962 | -9.4% | 0.00% | 0.0% |
Q4 2018 | $221,000 | -34.8% | 6,578 | -18.2% | 0.00% | -50.0% |
Q3 2018 | $339,000 | +3.0% | 8,037 | -21.9% | 0.00% | 0.0% |
Q2 2018 | $329,000 | -37.8% | 10,287 | -3.4% | 0.00% | -33.3% |
Q1 2018 | $529,000 | -16.6% | 10,647 | -9.5% | 0.00% | 0.0% |
Q4 2017 | $634,000 | -16.2% | 11,765 | -9.8% | 0.00% | -25.0% |
Q3 2017 | $757,000 | +10.7% | 13,046 | -5.9% | 0.00% | +33.3% |
Q2 2017 | $684,000 | +13.4% | 13,871 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $603,000 | +4.5% | 13,871 | +17.8% | 0.00% | 0.0% |
Q4 2016 | $577,000 | +2.3% | 11,778 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $564,000 | -10.8% | 11,778 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $632,000 | +19.9% | 11,778 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $527,000 | +20.0% | 11,778 | +2.4% | 0.00% | 0.0% |
Q4 2015 | $439,000 | +15.5% | 11,500 | 0.0% | 0.00% | +50.0% |
Q2 2015 | $380,000 | -21.2% | 11,500 | -1.7% | 0.00% | -33.3% |
Q1 2015 | $482,000 | +1.0% | 11,700 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $477,000 | – | 11,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |